Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Starpharma Holdings Ltd
OTC:SPHRY
Starpharma Holdings Ltd
OTC:SPHRY
Price:
3.25
USD
-7.14%
Market Closed
Market Cap:
$133.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Starpharma Holdings Ltd
OTC:SPHRY
|
AU |
|
Insulet Corp
NASDAQ:PODD
|
US |
|
Align Technology Inc
NASDAQ:ALGN
|
US |
|
R
|
Regions Financial Corp
SWB:RN7
|
US |
|
Scor SE
SIX:SCR
|
FR |
|
C
|
Chongqing Rural Commercial Bank Co Ltd
XMUN:C3B
|
CN |
|
R
|
Roper Technologies Inc
F:ROP
|
US |
|
Ezaki Glico Co Ltd
F:5EJ
|
JP |
|
IPH Ltd
F:1IP
|
AU |
|
C
|
Chongqing Rural Commercial Bank Co Ltd
F:C3B
|
CN |
|
R
|
Regions Financial Corp
XMUN:RN7
|
US |
|
CNS Pharmaceuticals Inc
NASDAQ:CNSP
|
US |
Wall St Price Targets
SPHRY Price Forecast
Based on 5 analysts
Based on 5 analysts
+97% Upside
from
$3.25
today
Starpharma Holdings Ltd (SPHRY)’s 12-month stock price forecast through October 2027 has a consensus target of $6.41, implying 97% upside. The forecast is based on price targets from 5 Wall Street analysts.
SPHRY Analyst Rating
No ratings yet
No ratings yet
Starpharma Holdings Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SPHRY's stock price target?
Price Target
6.41
USD
6.41
USD
According to Wall Street analysts, the average 1-year price target for SPHRY is 6.41 USD with a low forecast of 3.57 USD and a high forecast of 9.48 USD.
What is the Revenue forecast for Starpharma Holdings Ltd?
Projected CAGR
68%
68%
Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 68%.
What is the Gross Profit forecast for Starpharma Holdings Ltd?
Projected CAGR
12%
12%
The compound annual growth rate for Gross Profit over the next 2 years is 12%.